CompletedNCT03302312

Effectiveness of Effectiveness and Acceptability of Right-sided Stellate Ganglion Block in PTSD

It tested Effectiveness and Acceptability of Right-sided Stellate Ganglion Block for PTSD.

PTSDObservationalOver 18 Years

The study in practice

Understand this study

Listed age limits: from 18 years.

Listed locations: Honolulu, United States · Fort Bragg, United States and 1 more locationSee all locations and recruitment

Compensation and expense reimbursement have not been verified for this summary.

Study clarity

Study start dateStarted: November 3, 2017

Recruitment status: Completed
Enrollment listed in the registry: 54
Sponsor: RTI International
Sponsor type: Unknown or unclear
Study type: Observational
Intervention type: Interview / survey / observational
Study phase: Not clearly listed
Locations: United States, Germany
Age range: Over 18 Years
Official registry ID: NCT03302312
Official title: A Randomized, Sham-procedure-controlled, Blinded Study to Evaluate the Effectiveness and Acceptability of Right-sided Stellate Ganglion Block for Treatment of Posttraumatic Stress Disorder Symptoms - Acceptability

Completed

Honolulu, United States · Fort Bragg, United States · Landstuhl, Germany

FAQ

Who is behind this study?

The study sponsor is RTI International.

Who was this study for?

Listed age limits: from 18 years.

Explore other studies

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.